Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2017 | 10-2016 | 07-2016 | 04-2016 | 01-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 340 | 100 | 130 | 1,140 | 570 |
| Marketable Securities | 970 | 1,560 | 680 | 0 | 0 |
| Receivables | 10 | 10 | 0 | 10 | 10 |
| Other current assets | 20 | 10 | 10 | 20 | 10 |
| TOTAL | $1,340 | $1,680 | $820 | $1,170 | $590 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 0 | 20 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $20 |
| Total Assets | $1,350 | $1,680 | $820 | $1,170 | $610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10 | 30 | 50 | 70 | 80 |
| TOTAL | $10 | $30 | $50 | $70 | $80 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10 | $30 | $50 | $70 | $80 |
| Shareholders' Equity | |||||
| Common Shares | 4,130 | 4,170 | 3,390 | 3,440 | 2,800 |
| Retained earnings | -4,750 | -4,500 | -4,220 | -3,970 | -3,550 |
| Other shareholders' equity | 1,960 | 1,980 | 1,610 | 1,620 | 1,280 |
| TOTAL | $1,340 | $1,650 | $780 | $1,090 | $530 |
| Total Liabilities And Equity | $1,350 | $1,680 | $830 | $1,160 | $610 |